search
Back to results

Expiratory Muscle Strength Training for Hypernasal Speech in Children

Primary Purpose

Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate, Inadequate Velopharyngeal Closure

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Expiratory Muscle Strength Training
Maintenance Training
Sponsored by
Noel Jabbour
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Velopharyngeal Insufficiency focused on measuring Cleft Palate, Speech Intelligibility

Eligibility Criteria

5 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pittsburgh weighted speech scores of 3 or greater
  • Ages 5-17 years

Exclusion Criteria:

  • Previous speech surgery (e.g. palatoplasty or pharyngeal flap)
  • Speech surgery scheduled within the next 56 days
  • Unable or unwilling to perform the tests and exercises outlined in the study

Sites / Locations

  • UPMC Children's Hospital of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

No Intervention

Experimental

Experimental

Arm Label

Expiratory Muscle Strength Training + No Maintenance Training

No Exercises

Expiratory Muscle Strength Training + Maintenance Training

Expiratory Muscle Strength Training

Arm Description

These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They had improvement in their speech score of 2 points or more and were randomized to complete 6 months of no maintenance training.

These participants were initially randomized to 6-8 weeks of no exercises. They ended active study participation after the initial 6-8 weeks of no exercises. They were not eligible to be randomized to maintenance training or no maintenance training.

These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They had improvement in their speech score of 2 points or more and were randomized to complete 6 months of maintenance training.

These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They did not have improvement in their speech score of 2 points or more and ended active study participation after the initial 6-8 weeks of exercises.

Outcomes

Primary Outcome Measures

Change in nasalance scores after 6-8 weeks of exercises compared with baseline
Percent change in nasalance measured during nasometry
Change in perceptual speech symptoms of velopharyngeal dysfunction following 6-8 weeks of exercises compared with baseline
Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with ≥7 indicating likely velopharyngeal incompetence
Change in oral pressure following 6-8 weeks of exercises compared with baseline
Percent change in oral pressure achieved when blowing through the EMST-150
Change in velopharyngeal flutter following 6-8 weeks of exercises compared with baseline
Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150
Change in oral pressure decay following 6-8 weeks of exercises compared with baseline
Ratio of the magnitude of oral pressure decay when blowing through the EMST-150

Secondary Outcome Measures

Change in VELO questionnaire scores following 6-8 weeks of exercises compared with baseline
Percent change in Velopharyngeal Insufficiency (VPI) Effects on Life Outcomes (VELO) scores. Scores range from 0 - 100, with 100 representing the highest QOL
Resolution of type B tympanogram following 6-8 weeks of exercises compared with baseline.
Percentage of participants with a change in tympanogram type from type B (flat) to type A (normal middle ear function).
Resolution of type C tympanogram following 6-8 weeks of exercises compared with baseline.
Percentage of participants with a change in tympanogram type from type C (negative pressure) to type A (normal middle ear function).
Resolution of effusion following 6-8 weeks of exercises compared with baseline.
Percentage of participants with resolution of middle ear effusion based on otoscopy.
Resolution of retraction following 6-8 weeks of exercises compared with baseline.
Percentage of participants with resolution of tympanic membrane retraction based on otoscopy

Full Information

First Posted
August 4, 2022
Last Updated
October 4, 2023
Sponsor
Noel Jabbour
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
search

1. Study Identification

Unique Protocol Identification Number
NCT05492266
Brief Title
Expiratory Muscle Strength Training for Hypernasal Speech in Children
Official Title
Expiratory Muscle Strength Training as a Non-surgical Option for Velopharyngeal Dysfunction: A Randomized-controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
May 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Noel Jabbour
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the ability of the soft palate to close the area between the throat and nose and help improve speech.
Detailed Description
The objective of this study is to examine the feasibility and efficacy of expiratory muscle strength training to improve velopharyngeal closure in patients with velopharyngeal dysfunction and nasal air emissions. A randomized, controlled trial will be conducted at a cleft craniofacial center at a tertiary children's hospital. Patients will be block randomized based on Pittsburgh Weighted Speech Scale (PWSS) score (3-6 or 7+) to Expiratory Muscle Strength Training for 6 to 8 weeks or no exercises. Patients with reductions in PWSS during this time will be further randomized to EMST maintenance training for 6 months or no exercises.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate, Inadequate Velopharyngeal Closure, Palatopharyngeal Incompetence, Hypernasality
Keywords
Cleft Palate, Speech Intelligibility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Expiratory Muscle Strength Training + No Maintenance Training
Arm Type
Experimental
Arm Description
These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They had improvement in their speech score of 2 points or more and were randomized to complete 6 months of no maintenance training.
Arm Title
No Exercises
Arm Type
No Intervention
Arm Description
These participants were initially randomized to 6-8 weeks of no exercises. They ended active study participation after the initial 6-8 weeks of no exercises. They were not eligible to be randomized to maintenance training or no maintenance training.
Arm Title
Expiratory Muscle Strength Training + Maintenance Training
Arm Type
Experimental
Arm Description
These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They had improvement in their speech score of 2 points or more and were randomized to complete 6 months of maintenance training.
Arm Title
Expiratory Muscle Strength Training
Arm Type
Experimental
Arm Description
These participants were initially randomized to complete 6-8 weeks of exercises with EMST-150. They did not have improvement in their speech score of 2 points or more and ended active study participation after the initial 6-8 weeks of exercises.
Intervention Type
Device
Intervention Name(s)
Expiratory Muscle Strength Training
Other Intervention Name(s)
EMST-150
Intervention Description
At visit 1, participants will be block randomized based on PWSS score (3-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises. Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.
Intervention Type
Device
Intervention Name(s)
Maintenance Training
Intervention Description
At visit 2, participants with improved (decreased) PWSS of 2 or more points, for whom the family and/or surgeon is not currently considering surgical intervention for VPI, will be further randomized to continue "maintenance" EMST exercises or no exercises for 6 months. Participants in the "maintenance" group will complete 3-5 sessions exercise sessions each week (rather than daily training), with 2 sets of 5 resistive expirations (rather than 5 sets)
Primary Outcome Measure Information:
Title
Change in nasalance scores after 6-8 weeks of exercises compared with baseline
Description
Percent change in nasalance measured during nasometry
Time Frame
Baseline and 6-8 weeks
Title
Change in perceptual speech symptoms of velopharyngeal dysfunction following 6-8 weeks of exercises compared with baseline
Description
Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with ≥7 indicating likely velopharyngeal incompetence
Time Frame
Baseline and 6-8 weeks
Title
Change in oral pressure following 6-8 weeks of exercises compared with baseline
Description
Percent change in oral pressure achieved when blowing through the EMST-150
Time Frame
Baseline and 6-8 weeks
Title
Change in velopharyngeal flutter following 6-8 weeks of exercises compared with baseline
Description
Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150
Time Frame
Baseline and 6-8 weeks
Title
Change in oral pressure decay following 6-8 weeks of exercises compared with baseline
Description
Ratio of the magnitude of oral pressure decay when blowing through the EMST-150
Time Frame
Baseline and 6-8 weeks
Secondary Outcome Measure Information:
Title
Change in VELO questionnaire scores following 6-8 weeks of exercises compared with baseline
Description
Percent change in Velopharyngeal Insufficiency (VPI) Effects on Life Outcomes (VELO) scores. Scores range from 0 - 100, with 100 representing the highest QOL
Time Frame
Baseline and 6-8 weeks
Title
Resolution of type B tympanogram following 6-8 weeks of exercises compared with baseline.
Description
Percentage of participants with a change in tympanogram type from type B (flat) to type A (normal middle ear function).
Time Frame
Baseline and 6-8 weeks
Title
Resolution of type C tympanogram following 6-8 weeks of exercises compared with baseline.
Description
Percentage of participants with a change in tympanogram type from type C (negative pressure) to type A (normal middle ear function).
Time Frame
Baseline and 6-8 weeks
Title
Resolution of effusion following 6-8 weeks of exercises compared with baseline.
Description
Percentage of participants with resolution of middle ear effusion based on otoscopy.
Time Frame
Baseline and 6-8 weeks
Title
Resolution of retraction following 6-8 weeks of exercises compared with baseline.
Description
Percentage of participants with resolution of tympanic membrane retraction based on otoscopy
Time Frame
Baseline and 6-8 weeks
Other Pre-specified Outcome Measures:
Title
Change in nasalance scores after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Description
Percent change in nasalance measured during nasometry
Time Frame
6-8 weeks and 8 months
Title
Change in perceptual speech symptoms of velopharyngeal dysfunction after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Description
Perceptual symptoms of velopharyngeal incompetence measured using the Pittsburgh Weighted Speech Score, on a scale of 0-23, with ≥7 indicating likely velopharyngeal incompetence
Time Frame
6-8 weeks and 8 months
Title
Change in oral pressure after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Description
Percent change in pressure achieved when blowing through the EMST-150
Time Frame
6-8 weeks and 8 months
Title
Change in velopharyngeal flutter after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Description
Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150
Time Frame
6-8 weeks and 8 months
Title
Change in oral pressure decay after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises
Description
Ratio of the magnitude of oral pressure decay when blowing through the EMST-150
Time Frame
6-8 weeks and 8 months
Title
Prevalence of surgical intervention
Description
Percentage of patients undergoing surgical intervention for speech symptoms within the 1 year following enrollment
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pittsburgh weighted speech scores of 3 or greater Ages 5-17 years Exclusion Criteria: Previous speech surgery (e.g. palatoplasty or pharyngeal flap) Speech surgery scheduled within the next 56 days Unable or unwilling to perform the tests and exercises outlined in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amber D Shaffer, PhD
Phone
412-692-6874
Email
shafferad@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Noel Jabbour, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
UPMC Children's Hospital of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15224
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amber D Shaffer, PhD
Phone
412-692-6874
Email
shafferad@upmc.edu
First Name & Middle Initial & Last Name & Degree
Cuneyt Alper, MD
First Name & Middle Initial & Last Name & Degree
Daniel Awad, MS
First Name & Middle Initial & Last Name & Degree
Matthew Ford, MS
First Name & Middle Initial & Last Name & Degree
Jesse Goldstein, MD
First Name & Middle Initial & Last Name & Degree
Joseph Losee, MD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data (IPD) that underlie the results reported in a publication may be shared, after de-identification.
IPD Sharing Time Frame
Beginning 1 year after publication of summary data. Ending 5 years after publication.
IPD Sharing Access Criteria
IPD will be shared with researchers who provide a methodologically sound proposal. IPD to be shared will include that necessary to achieve the aims in the approved proposal. Proposals should be directed to shafferad@upmc.edu. To gain access, data requestors will need to sign data access agreement.

Learn more about this trial

Expiratory Muscle Strength Training for Hypernasal Speech in Children

We'll reach out to this number within 24 hrs